<code id='AEF44568C0'></code><style id='AEF44568C0'></style>
    • <acronym id='AEF44568C0'></acronym>
      <center id='AEF44568C0'><center id='AEF44568C0'><tfoot id='AEF44568C0'></tfoot></center><abbr id='AEF44568C0'><dir id='AEF44568C0'><tfoot id='AEF44568C0'></tfoot><noframes id='AEF44568C0'>

    • <optgroup id='AEF44568C0'><strike id='AEF44568C0'><sup id='AEF44568C0'></sup></strike><code id='AEF44568C0'></code></optgroup>
        1. <b id='AEF44568C0'><label id='AEF44568C0'><select id='AEF44568C0'><dt id='AEF44568C0'><span id='AEF44568C0'></span></dt></select></label></b><u id='AEF44568C0'></u>
          <i id='AEF44568C0'><strike id='AEF44568C0'><tt id='AEF44568C0'><pre id='AEF44568C0'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:3522
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          2024 GOP presidential candidates spar over abortion in debate
          2024 GOP presidential candidates spar over abortion in debate

          APPhoto/MorryGashWASHINGTON—RepublicanpresidentialcandidatessparredWednesdayoveraquestionthathashaun

          read more
          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more

          Study finds new variant for Parkinson’s in African populations

          AdobeAgroupofNigerian,British,andU.S.doctorshavediscoveredageneticvariantthatincreasestheriskofParki